Loading clinical trials...
Loading clinical trials...
This Phase 1, randomized, placebo-controlled, double-blind, healthy volunteer study tested the safety, tolerability, and plasma pharmacokinetics of two different concentrations of TAT4 Gel administere...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Topokine Therapeutics, Inc.
NCT03087253 · Lipodystrophy (Genetic or Acquired, Non HIV)
NCT05996536 · Lipodystrophy
NCT06679270 · Familial Partial Lipodystrophy
NCT03553420 · Lipodystrophy Acquired, Lipodystrophy Congenital
NCT06484868 · Partial Lipodystrophy
Topokine Clinical Site
Cypress, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions